Patient Provider Communication and Interaction in a Virtual Clinical Setting

NCT ID: NCT00669188

Last Updated: 2024-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

326 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-04-24

Study Completion Date

2020-07-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Summary:

A few studies have explored factors which influence patient-provider communication in a controlled setting. However, more information is needed about how different factors affect communication so that it can be improved.

Third- and fourth-year medical students may be eligible for this study. Participants are recruited from the Washington, D.C. area.

At the research center, participants will use a virtual reality headset to view a virtual clinic environment and interact with a virtual patient.

After interacting with the virtual patient, participants will complete a questionnaire about their experience within the virtual clinic and other research-related information.

The total time for the study visit is 60 minutes.

Eligibility:

Third- and fourth-year medical students at least 18 years of age. You may not take part in the study if you have a history of seizures and/or are pregnant.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will investigate research questions regarding factors influencing patient-provider communication. Participants will interact with a virtual patient in a virtual clinical setting.

Third- or fourth-year medical students may be eligible for this study. Participants are recruited from the Washington, D.C. area.

Study participants will perform one task and complete one set of questions at the study appointment. The task involves viewing a virtual patient s health information and interacting with the virtual patient in a virtual environment clinical scenario. While in the virtual environment, the subject wears a head-mounted video unit that allows him or her to see elements of the environment. The activities in the virtual environment take about 15 minutes. The total time for the study is about 60 minutes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Information Type 1

genetic risk information

Group Type EXPERIMENTAL

Information

Intervention Type OTHER

Information

Information Type 2

information absent

Group Type SHAM_COMPARATOR

Information absent

Intervention Type OTHER

Information

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Information absent

Information

Intervention Type OTHER

Information

Information

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Healthy adult volunteers who are third or fourth-year medical students. Both men and women over age 18 will be eligible for this study (though in practice the age range is likely to naturally be constrained by the typical age of medical students).

Exclusion Criteria

NHGRI; and 6) persons who have received information about the study purpose or procedure from a past participant.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Human Genome Research Institute (NHGRI)

NIH

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Susan Persky, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

National Human Genome Research Institute (NHGRI)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

08-HG-0122

Identifier Type: -

Identifier Source: secondary_id

080122

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Improving Patient-centered Care Using an Inventory
NCT01843803 COMPLETED PHASE2/PHASE3